22nd Century Debt to Equity Ratio 2012-2026 | XXII

Current and historical debt to equity ratio values for 22nd Century (XXII) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. 22nd Century debt/equity for the three months ending June 30, 2026 was 0.02.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
22nd Century Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2026-06-30 $0.01B $0.02B 0.40
2026-03-31 $0.01B $0.02B 0.43
2025-12-31 $0.01B $0.02B 0.46
2025-09-30 $0.01B $0.02B 0.53
2025-06-30 $0.02B $0.01B 2.98
2025-03-31 $0.02B $0.00B 4.92
2024-12-31 $0.02B $0.00B 4.40
2024-09-30 $0.02B $0.00B 6.54
2024-06-30 $0.03B $0.00B -26.22
2024-03-31 $0.04B $-0.01B -3.12
2023-12-31 $0.04B $-0.01B -4.27
2023-09-30 $0.05B $0.01B 3.65
2023-06-30 $0.05B $0.07B 0.72
2023-03-31 $0.04B $0.08B 0.53
2022-12-31 $0.02B $0.10B 0.20
2022-09-30 $0.02B $0.12B 0.17
2022-06-30 $0.02B $0.10B 0.20
2022-03-31 $0.01B $0.06B 0.15
2021-12-31 $0.01B $0.07B 0.15
2021-09-30 $0.01B $0.08B 0.09
2021-06-30 $0.01B $0.09B 0.11
2021-03-31 $0.01B $0.05B 0.14
2020-12-31 $0.01B $0.04B 0.17
2020-09-30 $0.01B $0.05B 0.15
2020-06-30 $0.01B $0.05B 0.14
2020-03-31 $0.01B $0.06B 0.11
2019-12-31 $0.01B $0.06B 0.11
2019-09-30 $0.01B $0.06B 0.12
2019-06-30 $0.01B $0.06B 0.13
2019-03-31 $0.01B $0.07B 0.11
2018-12-31 $0.01B $0.07B 0.08
2018-09-30 $0.01B $0.08B 0.09
2018-06-30 $0.01B $0.07B 0.08
2018-03-31 $0.01B $0.08B 0.07
2017-12-31 $0.00B $0.08B 0.06
2017-09-30 $0.00B $0.03B 0.13
2017-06-30 $0.00B $0.03B 0.17
2017-03-31 $0.00B $0.02B 0.16
2016-12-31 $0.00B $0.02B 0.14
2016-09-30 $0.00B $0.02B 0.21
2016-06-30 $0.00B $0.01B 0.27
2016-03-31 $0.00B $0.02B 0.24
2015-12-31 $0.01B $0.01B 0.57
2015-09-30 $0.01B $0.01B 0.48
2015-06-30 $0.01B $0.02B 0.41
2015-03-31 $0.01B $0.01B 0.54
2014-12-31 $0.01B $0.02B 0.44
2014-09-30 $0.01B $0.02B 0.33
2014-06-30 $0.00B $0.01B 0.23
2014-03-31 $0.00B $0.01B 0.17
2013-12-31 $0.01B $0.01B 0.63
2013-09-30 $0.02B $-0.02B -1.23
2013-06-30 $0.01B $-0.01B -1.44
2013-03-31 $0.01B $-0.01B -1.38
2012-12-31 $0.01B $-0.01B -1.43
2012-09-30 $0.01B $0.00B -2.12
2012-06-30 $0.01B $0.00B -2.34
2012-03-31 $0.01B $0.00B -1.79
2011-12-31 $0.00B $0.00B -2.97
2011-09-30 $0.01B $0.00B -1.76
2011-06-30 $0.01B $0.00B -2.02
2011-03-31 $0.01B $0.00B -2.92
2010-12-31 $0.01B $0.00B -2.35
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.001B $0.018B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $302.542B 23.96
Altria (MO) United States $116.565B 12.58
British American Tobacco (BTI) United Kingdom $114.738B 0.00
JAPAN TOB (JAPAY) Japan $77.655B 24.03
Imperial Tobacco Group (IMBBY) United Kingdom $25.912B 0.00
Turning Point Brands (TPB) United States $1.356B 30.05
Universal (UVV) United States $1.104B 21.42
Air Global (AIIR) United States $0.288B 0.00
Ispire Technology (ISPR) United States $0.083B 0.00